Advertisement
Advertisement

PHGE

PHGE logo

BiomX Inc.

0.63
USD
Sponsored
+0.01
+1.28%
May 08, 15:55 UTC -4
Closed
exchange

After-Market

0.63

0.00
0.00%

PHGE Earnings Reports

Positive Surprise Ratio

PHGE beat 12 of 23 last estimates.

52%

Next Report

In 3 Days
Date of Next Report
May 13, 2026
Estimate for Q1 26 (Revenue/ EPS)
--
/
--
Implied change from Q4 25 (Revenue/ EPS)
--
/
--
Implied change from Q1 25 (Revenue/ EPS)
--
/
--

BiomX Inc. earnings per share and revenue

On Feb 19, 2026, PHGE reported earnings of -8.17 USD per share (EPS) for Q4 25, missing the estimate of -4.70 USD, resulting in a -73.75% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -0.38% price change (close before vs. close after earnings).
Looking ahead to Q1 26, -- analysts forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Rockwell Medical, Inc. (DE) Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.02
Actual
-$0.04
Surprise
-56.86%
logo
Nephros Inc.
Report Date
May 07, 2026 For Q1 26
Estimate
$0.01
Actual
$0.01
Surprise
-1.96%
logo
Myomo Inc.
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.11
Actual
-$0.09
Surprise
+21.81%
logo
Lantheus Holdings, Inc
Report Date
May 07, 2026 For Q1 26
Estimate
$1.26
Actual
$1.46
Surprise
+15.85%
logo
ICU Medical Inc
Report Date
May 07, 2026 For Q1 26
Estimate
$1.78
Actual
$1.97
Surprise
+10.26%
logo
Haemonetics Corporation
Report Date
May 07, 2026 For Q4 26
Estimate
$1.28
Actual
$1.29
Surprise
+0.42%
logo
BioLife Solutions Inc.
Report Date
May 07, 2026 For Q1 26
Estimate
$0.02
Actual
$0.04
Surprise
+96.08%
logo
Maravai LifeSciences Holdings, Inc. Class A Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.04
Actual
$0.01
Surprise
+120.79%
logo
Varex Imaging Corporation Common Stock
Report Date
May 07, 2026 For Q2 26
Estimate
$0.21
Actual
$0.21
Surprise
-1.82%
logo
InfuSystem Holdings, Inc.
Report Date
May 07, 2026 For Q1 26
Estimate
$0.03
Actual
$0.05
Surprise
+46.63%
FAQ
For Q4 2025, BiomX Inc. reported EPS of -$8.17, missing estimates by -73.75%, and revenue of $0.00, 0% as expectations.
The stock price moved down -0.38%, changed from $5.25 before the earnings release to $5.23 the day after.
The next earning report is scheduled for May 13, 2026.
Based on -- analysts, BiomX Inc. is expected to report EPS of -- and revenue of -- for Q1 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement